Medicinova (NASDAQ: MNOV), a Company developing small molecule therapeutics, has received notice of allowances for grant of new patents for MN-166 (ibudilast) for the treatment of amyotrophic lateral sclerosis (ALS) from the Canadian Intellectual Property Office, in addition to receiving a Notice of Allowance for...
The Global legal marijuana market is likely to reach over USD 66.3 billion by the end of 2025, as per a report by Grand View Research, Inc, growing at a CAGR of 23.9%. There is a growing acceptance of the curative effects of cannabis, with...
HLS Therapeutics Inc (OTCPINK: HLTRF), a specialty pharmaceutical Company developing solutions for the treatment of central nervous system and cardiovascular disorders, announced the grant of a medical device license for the Athela One WBS system. Indicated to serve as a point-of-care device, it is capable...
In a considerable setback, Aphria (NYSE: APHA), one of the largest cannabis companies in the world, has lost a supply deal with Emblem (OTCPINK: EMMOF), a subsidiary of Aleafia Health (OTCQX: ALEAF), after failing to meet its supply obligations to the Company. Emblem has terminated...
The U.S House of Representatives passed a landmark legislation namely Secure And Fair Enforcement (SAFE) Banking Act (H.R 1595), which will provide access to banking and financial services to the cannabis industry, in spite of Marijuana still being a schedule A illegal substance under federal...
The Global legal marijuana market is likely to reach over USD 66.3 billion by the end of 2025, as per a report by Grand View Research, Inc, growing at a CAGR of 23.9%. There is a growing acceptance of the curative effects of cannabis, with...
Aytu BioScience (NASDAQ: AYTU), a specialty pharmaceutical Company engaged in developing solutions for unmet needs in areas such as virility, reproductive health, severe cough and insomnia, has entered into a definitive agreement with Innovus Pharmaceuticals (OTCQB: INNV) for acquisition of the company. The deal is...
Neurotrope Inc, (NASDAQ: NTRP) announced a setback, with Bryostatin, its lead candidate for the treatment of Alzheimer’s, failing to meet its clinical endpoints of its mid-stage study. The Topline results from the confirmatory Phase 2 study of Bryostatin-1, in moderate to severe Alzheimer’s, failed to achieve...
Medicine Man Technologies (OTCQX: MDCL), a company providing cannabis consulting, nutrients and supplies, announced that it has entered into a binding term sheet agreement with Starbuds, to purchase four dispensaries in Colorado, in consideration for a cash, stock and a deferred payment deal. These four...
KemPharm (NASDAQ: KMPH), a specialty pharmaceutical company, has entered into a collaboration and licensing agreement with an affiliate of Gurnet Point Capital (GPC) in exchange for an upfront payment of $10 million, in addition to receiving pre-approval cost reimbursements, regulatory milestone and sales milestone amounting...
